These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38495192)

  • 1. Consumption of non-antibacterial drugs may have negative impact on
    Atif AN; Hatefi A; Arven A; Foroumadi A; Kadkhodaei S; Sadjadi A; Siavoshi F
    Heliyon; 2024 Mar; 10(5):e27327. PubMed ID: 38495192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Disc Diffusion and Agar Dilution Methods in Evaluating
    Mansour-Ghanaei F; Poostizadeh G; Joukar F; Siavoshi F
    Middle East J Dig Dis; 2022 Apr; 14(2):207-213. PubMed ID: 36619148
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.
    Huang X; Liu Y; Lin Z; Wu B; Nong G; Chen Y; Lu Y; Ji X; Zhou X; Suo B; Chen Q; Wei J
    PLoS One; 2021; 16(9):e0256225. PubMed ID: 34473713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Primary Antibiotic Resistance of
    Krzyżek P; Pawełka D; Iwańczak B; Kempiński R; Leśniakowski K; Mégraud F; Łaczmański Ł; Biernat M; Gościniak G
    Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32370201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
    Siavoshi F; Saniee P; Malekzadeh R
    Helicobacter; 2018 Dec; 23(6):e12531. PubMed ID: 30230637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antagonistic activity of Lactobacillus casei against Helicobacter pylori.
    Enany S; Abdalla S
    Braz J Microbiol; 2015; 46(4):1201-6. PubMed ID: 26691482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Resistance of
    Vu TB; Tran TNQ; Tran TQA; Vu DL; Hoang VT
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676631
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic Resistance of
    Le LTT; Nguyen TA; Nguyen NA; Nguyen YTH; Nguyen HTB; Nguyen LT; Vi MT; Nguyen T
    Healthcare (Basel); 2022 Jun; 10(6):. PubMed ID: 35742177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing.
    Yokota K; Osaki T; Hayashi S; Yokota SI; Takeuchi H; Rimbara E; Ojima H; Sato T; Yonezawa H; Shibayama K; Tokunaga K; Kamiya S; Murakami K; Kato M; Sugiyama T
    Helicobacter; 2022 Jun; 27(3):e12874. PubMed ID: 35255160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
    Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
    J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for
    Choi YI; Lee SM; Chung JW; Kim KO; Kwon KA; Kim YJ; Kim JH; Lee SM; Jeong JY; Park DK
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
    Makobongo MO; Einck L; Peek RM; Merrell DS
    PLoS One; 2013; 8(7):e68917. PubMed ID: 23935905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori Multidrug Resistance Due to Misuse of Antibiotics in Iran.
    Saniee P; Hosseini F; Kadkhodaei S; Siavoshi F; Khalili-Samani S
    Arch Iran Med; 2018 Jul; 21(7):283-288. PubMed ID: 30041525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype and genotype analysis for
    Xiong M; Mohammed Aljaberi HS; Khalid Ansari N; Sun Y; Yin S; Nasifu L; Sun H; Xu T; Pan Y; Nie Z; Liu C; Zhang Z; Jiang Z; Wang S; He B
    Microbiol Spectr; 2023 Sep; 11(5):e0055023. PubMed ID: 37732751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance profile of
    Huang X; Wu B; Chen Q; Chen Y; Ji X; Zhou X; Suo B; Lin Z; Zheng X
    PeerJ; 2023; 11():e15611. PubMed ID: 37456872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori.
    Filocamo A; Bisignano C; Ferlazzo N; Cirmi S; Mandalari G; Navarra M
    BMC Complement Altern Med; 2015 Jul; 15():256. PubMed ID: 26220068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of resistance to metronidazole in Helicobacter pylori from children and induction of resistance in vitro].
    Hu HJ; Chen J; Yan WH; Zhang XP
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):765-8. PubMed ID: 18211761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.